Cetera Investment Advisers
BSX icon

Cetera Investment Advisers’s Boston Scientific BSX Stock Holding History

Cetera Investment Advisers’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.55K Buy
+8,500
New +$680K ﹤0.01% 4731

Other funds holding BSX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Cetera Investment Advisers's BSX Position: Q1 2026 in Review

Cetera Investment Advisers increased its Boston Scientific (BSX) stake by 5.2% in Q1 2026, buying an estimated $1.86M and bringing the position to 473,400 shares worth $29.7M. The position accounts for 0.03% of the portfolio, ranked #531.

Cetera Investment Advisers first reported a position in BSX in Q4 2020 and has held it in 22 quarters since. The position peaked at $43.2M in Q3 2025. 1,666 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

  • Cetera Investment Advisers held 473,400 shares of Boston Scientific worth $29.7M as of Q1 2026.
  • Cetera Investment Advisers bought 23,257 Boston Scientific shares in Q1 2026, an estimated $1.86M.
  • Boston Scientific made up 0.03% of Cetera Investment Advisers's portfolio in Q1 2026, its #531 holding.
  • Cetera Investment Advisers first reported a position in Boston Scientific in Q4 2020 and has held it in 22 quarters since.
  • Cetera Investment Advisers's Boston Scientific position peaked at $43.2M in Q3 2025.
  • 1,666 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Cetera Investment Advisers's 13F filing for Q1 2026, filed 13 May 2026.